Authors
Latest:
Assessing Outcomes in Child PsychiatryTwo standardized rating scales appeared to be valid and reliable for use at admission and possibly follow-up in a child psychiatry system of care.
Latest:
Improving Influenza Immunization in Pregnant Women and Healthcare WorkersInfluenza vaccination rates in pregnant women and healthcare workers were increased with standing orders, vaccine advocates, and educational activities on influenza immunization.
Latest:
Impact of a Scalable Care Transitions Program for Readmission AvoidanceThe 30-day readmission risk was reduced 25% by a collaborative program model employing discharge planning and telephonic follow-up for high-risk patients with CMS penalty diagnoses.
Latest:
Understanding and Improving Value Frameworks With Real-World Patient OutcomesNew value frameworks should incorporate real-world evidence that reflects patient treatment behavior, adherence to medication, and equity concerns arising from disparities in care.
Latest:
Cost-Effectiveness of 21-Gene Assay in Node-Positive, Early-Stage Breast CancerA decision-analytic model was used to estimate cost-effectiveness of adopting a 21-gene assay in treatment decisions for women with early-stage N (1-3)/ER HER2-negative breast cancer.
Latest:
Improving Quality of Care in Oncology Through Healthcare Payment ReformOverview of alternative payment models and how leading national organizations are involved with linking quality improvement initiatives and payment reform.
Latest:
A Step in the Digital Direction: From Paper Logs to Electronic Data CaptureResearch documentation is a critical aspect of running a clinical trial. Key patient information such as informed consent, adverse events (AEs), concomitant medications, and medical and surgical histories are collected and used to determine patient safety and efficacy as the trial proceeds. Ultimately, the sponsor may make decisions—ranging from modifying the dose of the investigational drug to closing the study due to AEs—based on the data collected.
Latest:
Previously Unrecognized Trends in Diabetes Consumption Clusters in MedicareMedicare beneficiaries with diabetes who are at the lowest levels of healthcare consumption often become some of the highest level consumers in subsequent years.
Latest:
Costs of Asthma Among US Working AdultsAmong a working population, patients with asthma experienced significantly higher direct medical costs and modestly higher work loss than patients without asthma.
Latest:
Is Integration in Large Medical Groups Associated With Quality?Integrated care systems allegedly provide better care. This study of 97 large medical groups nationally provides suggestive evidence that this may be true.
Latest:
Simply Delivered Meals: A Tale of CollaborationOffering a meal delivery service to patients in a community-based care transition program was associated with cost savings and a 38% lower 30-day hospital readmission rate.
Latest:
Using Financial Incentives to Improve the Care of Tuberculosis PatientsPatients enrolled in the tuberculosis pay-for-performance program received more comprehensive ambulatory care with slightly lower costs and a higher treatment success rate.
Latest:
Adjunctive Aripiprazole for Depression: Predictive Value of Early AssessmentIn treatment of depression with adjunctive aripiprazole, early improvement (week 2) was a significant predictor of remission, and lack of improvement was associated with nonremission.
Latest:
Effective Care Management by Next Generation Accountable Care OrganizationsA complex care management program implemented at 5 Next Generation accountable care organizations reduced all-cause inpatient admissions and total medical expenditures for participating beneficiaries.
Latest:
Healthcare Utilization and Cost Effects of Prior Authorization for Pregabalin in Commercial Health PlansPrior authorization for pregabalin in commercial insurance plans accomplished the objective of lower pregabalin utilization; however, there was no significant decrease in disease-related healthcare costs.
Latest:
Novel Approaches for the Prevention and Treatment of Inflammatory Bone LossCurrent novel therapeutics for the prevention and treatment of bone loss in patients with inflammatory joint disease target cytokines and other inflammatory mediators. Mesenchymal stem cell therapy is a compelling new treatment currently being studied in clinical trials.
